Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

Summary: Combination monoclonal broadly neutralizing antibody (bnAb) regimens are in clinical development for HIV prevention, necessitating additional knowledge of bnAb neutralization potency/breadth against circulating viruses. Williamson et al. (2021) described a software tool, Super LeArner Predi...

Full description

Bibliographic Details
Main Authors:	Brian D. Williamson, Craig A. Magaret, Shelly Karuna, Lindsay N. Carpp, Huub C. Gelderblom, Yunda Huang, David Benkeser, Peter B. Gilbert
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	iScience
Subjects:	Immunology Immunological methods Virology Mathematical biosciences
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589004223016723

Similar Items

Immune response to SARS-CoV-2 in severe disease and long COVID-19
by: Tomonari Sumi, et al.
Published: (2022-08-01)

Additional mutations based on Omicron BA.2.75 mediate its further evasion from broadly neutralizing antibodies
by: Huimin Guo, et al.
Published: (2023-04-01)

Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
by: Xiaoqing Guan, et al.
Published: (2023-10-01)

Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents
by: Masaru Takeshita, et al.
Published: (2023-06-01)

Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency
by: Nicole Frumento, et al.
Published: (2022-08-01)

Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
by: Denise Guerra, et al.
Published: (2023-10-01)

Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
by: Chuan Chen, et al.
Published: (2022-08-01)

19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
by: Melissa García-Vega, et al.
Published: (2023-04-01)

Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
by: Shinya Yamamoto, et al.
Published: (2023-07-01)

Molecular basis for antiviral activity of two pediatric neutralizing antibodies targeting SARS-CoV-2 Spike RBD
by: Yaozong Chen, et al.
Published: (2023-01-01)

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
by: Maya Imbrechts, et al.
Published: (2022-08-01)

Monovalent and trivalent VSV-based COVID-19 vaccines elicit neutralizing antibodies and CD8+ T cells against SARS-CoV-2 variants
by: Kate A. Parham, et al.
Published: (2023-04-01)

Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses
by: Laura Radić, et al.
Published: (2023-04-01)

Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses
by: Sudhakar Singh, et al.
Published: (2022-07-01)

Shaping Polyclonal Responses via Antigen-Mediated Antibody Interference
by: Le Yan, et al.
Published: (2020-10-01)

Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile
by: Edurne Rujas, et al.
Published: (2021-09-01)

Sequence and functional characterization of a public HIV-specific antibody clonotype
by: Amyn A. Murji, et al.
Published: (2022-01-01)

Standardized two-step testing of antibody activity in COVID-19 convalescent plasma
by: Pavlo Gilchuk, et al.
Published: (2022-01-01)

Monkeypox infection elicits strong antibody and B cell response against A35R and H3L antigens
by: Ron Yefet, et al.
Published: (2023-02-01)

Kinetics of viral DNA in body fluids and antibody response in patients with acute Monkeypox virus infection
by: Francesca Colavita, et al.
Published: (2023-03-01)

An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer
by: Naveenchandra Suryadevara, et al.
Published: (2022-06-01)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
by: Yannic C. Bartsch, et al.
Published: (2023-05-01)

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways
by: Fangzhu Zhao, et al.
Published: (2022-09-01)

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
by: Jakob Kreye, et al.
Published: (2023-04-01)

Hepatitis C virus hypervariable region 1 antibodies interrupt E2-SR-B1 interaction to suppress viral infection
by: Kai Deng, et al.
Published: (2023-04-01)

A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19
by: Friederike Krempe, et al.
Published: (2021-10-01)

An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals
by: Anna Offersgaard, et al.
Published: (2023-02-01)

Dynamically modeling the effective range of IL-2 dosage in the treatment of systemic lupus erythematosus
by: Xin Gao, et al.
Published: (2022-09-01)

Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses
by: Mitch Brinkkemper, et al.
Published: (2022-12-01)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
by: Zak A. Yaffe, et al.
Published: (2023-05-01)

Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
by: Huiru Wang, et al.
Published: (2022-10-01)

Polytopic vaccination with a live-attenuated dengue vaccine enhances B-cell and T-cell activation, but not neutralizing antibodies
by: Taweewun Hunsawong, et al.
Published: (2017-03-01)

Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection
by: Romel D. Mackelprang, et al.
Published: (2023-04-01)

The establishment of a cytomegalovirus -specific CD8+ T-cell threshold by kinetic modeling for the prediction of post-hemopoietic stem cell transplant reactivation
by: Jing Zhang, et al.
Published: (2022-11-01)

RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
by: Qingtai Liang, et al.
Published: (2022-04-01)

Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses
by: Sarah E. Lovelace, et al.
Published: (2022-10-01)

tANCHOR-cell-based assay for monitoring of SARS-CoV-2 neutralizing antibodies rapidly adaptive to various receptor-binding domains
by: Daniel Ivanusic, et al.
Published: (2024-03-01)

Innate immune recognition and evasion by viruses
by: Hertzog, J
Published: (2019)

Z-nucleic acids in virus-host interactions
by: Liverpool, L
Published: (2019)

Human Papillomavirus Type 16 L2 Gene Sequence Variation Analysis in Indonesian Cervical Cancer Specimens
by: Putra, Syandrez Prima, et al.
Published: (2022)